Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
358
datasets available to search
ShareScore release 0.9.0
Dataset results
358 results for “SAR studies”
A Study of the GRIP Influenza and SARS-CoV-2 POC Assays
ClinicalTrials.gov study NCT05674370. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)
ClinicalTrials.gov study NCT00423995. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High R
ClinicalTrials.gov study NCT04383548. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)
ClinicalTrials.gov study NCT00783146. IPD Sharing: Not stated. Countries: 0. Publications: 1.
COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers
ClinicalTrials.gov study NCT05181683. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis
ClinicalTrials.gov study NCT00882687. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)
ClinicalTrials.gov study NCT01458275. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Test Whether BI 767551 Can Prevent COVID-19 in People Who Have Been Exposed to SARS-CoV-2
ClinicalTrials.gov study NCT04894474. IPD Sharing: NO. Countries: 0. Publications: 2.
COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities
ClinicalTrials.gov study NCT04860258. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection
ClinicalTrials.gov study NCT05472090. IPD Sharing: NO. Countries: 1. Publications: 0.
COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hos
ClinicalTrials.gov study NCT05092581. IPD Sharing: YES. Countries: 1. Publications: 0.
A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults
ClinicalTrials.gov study NCT05142306. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants
ClinicalTrials.gov study NCT05584202. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)
ClinicalTrials.gov study NCT00612820. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen
ClinicalTrials.gov study NCT00291642. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SARS-CoV-2 Safety Study for the Treatment of COVID-19
ClinicalTrials.gov study NCT06489860. IPD Sharing: NO. Countries: 0. Publications: 1.
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
ClinicalTrials.gov study NCT04494646. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines
ClinicalTrials.gov study NCT05973006. IPD Sharing: NO. Countries: 1. Publications: 0.
Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh
Open the record for dataset details and reuse information.
The bradykinin-2 receptor antagonist, icatibant, improves lung function in patients with SARS-CoV2 associated ARDS - First results of a prospective off-label use patient-related observational study.
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.